According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published in Nature Medicine, the novel monoclonal antibody linavonkibart has demonstrated the ...

OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round. Despite years ...

Elation Health and HealthEx announced they are integrating Anthropic's Claude artificial intelligence to better synthesize health data for doctors and patients.

From 6,141 Qatari genomes the authors chart structural variants tied to large-scale protein data, biobank traits and everyday health measures. When combined with single nucleotide variants, they find ...